Safety Dermatological Evaluation of the Acceptability With Gynecological Follow up for Dermacyd Femina Delicata

Sanofi1 site in 1 country30 target enrollmentMay 2007

ConditionsHygiene

DrugsLactoserum

Overview

Phase: Phase 4
Intervention: Not specified
Conditions: Hygiene
Sponsor: Sanofi
Enrollment: 30
Locations: 1
Primary Endpoint: Clinical and local tolerability
Status: Completed
Last Updated: 17 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Femina Delicata.

Registry

clinicaltrials.gov

Start Date

May 2007

End Date

TBD

Last Updated

17 years ago

Study Type

Interventional

Study Design

Single Group

Sex

Female

Investigators

Sponsor

Sanofi

Eligibility Criteria

Inclusion Criteria

•Integral skin in the tested region

Exclusion Criteria

•Pregnancy or breastfeeding women
•Use of Anti-inflammatory or immune-suppression drugs
•Topical medication use at the tested region
•Active cutaneous gynaecological disease which may interfere in study results
•Personal history of allergic disease at the area to be treated
•Allergic or atopic history
•The above information is not intended to contain considerations relevant to a patient's potential participation in a clinical trial.